LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, ...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today ...

For more than 30 years, Dello Russo Laser Vision has been synonymous with innovation in vision correction. From its early work with LASIK to performing a high volume of procedures across the New York ...

Brinton Vision, a leader in advanced vision correction procedures, has published a new resource titled “Can EVO ICL treat astigmatism?” to help patients and reporters better understand how this ...

The FDA-approved EVO ICL lenses are successful in correcting myopia, which affects distance vision, and myopia with astigmatism, which causes blurred vision at all distances. As a professional athlete ...

Please provide your email address to receive an email when new articles are posted on . The EVO ICL is now approved for use in patients between the ages of 21 to 60 years. Clinical trial data ...

Competitive and recreational swimmers and divers face unique challenges when it comes to vision correction. Glasses are incompatible with aquatic sports, and contact lenses can lead to discomfort, ...

LAKE FOREST, Calif., Oct. 10, 2023 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, is proud to announce a ...

Prestigious three-year multicenter clinical trial confirms revolutionary implantable lens technology achieves exceptional visual outcomes with minimal complications Dr. Jason P. Brinton of Brinton ...

SEOUL, SOUTH KOREA, May 11, 2026 /EINPresswire.com/ — SNU Eye Clinic announced major international achievements at the Guangzhou EVO ICL Global Summit, reinforcing ...